CClinicalTrials.gg
CompletedNCT03967860LSG-CTUpdated Sep 23, 2026

Role of Post Surgery CT Following Laparoscopic Vertical Sleeve Gastrectomy

An observational study in Obesity, sponsored by Francesco De Cobelli. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Francesco De Cobelli · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

Obesity is a extremely widespread condition in Europe and North America, burdened by a series of complications characterized by major morbidity and morbility. In recent years, bariatric surgery has progressively assumed a leading role in the treatment of morbid obesity and restrictive bariatric surgery procedures, such as laparoscopic vertical sleeve gastrectomy are common.

The aim of the study is to retrospectively determine the value of postoperative CT after LSG as an early tool to identify risk factors for the subsequent development of gastric fistula and enable to stratify postoperative risk in asymptomatic patients and ensure effective management of these risk factors.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • CT Scan
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 250 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Francesco De Cobelli is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Obese patients with BMI ≥ 40 kg/m2 or between 35 e 40 kg/m2 with evidence of obesity related comorbidity

Inclusion criteria

  • adult obese patients with LSG
  • BMI ≥ 40 kg/m2 or BMI between 35 and 40 kg/m2
  • evidence of obesity related comorbidity
  • availability of upper abdomen CT scan with IV and oral contrast medium within 72 hours of surgery

Exclusion criteria

Exclusion Criteria:

  • Pregnant women
  • allergy to contract medium
  • lack of venous access
  • patients who did not have a post-surgical upper abdomen CT
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
250 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testCT scan

    Post surgical standard CT Scan as predictor of complication

06

What researchers measure

Primary outcomes

  1. Value of Post surgery CT in identifying risks for subsequent development of gastric fistula

    Measurements of: presence or abscence of fistula and site; presence/abscence of hematoma and site; presence/abscence of gastric torsion; Stapler to pylorus distance and stapler length

    Time frame: 72 hours post LSG

Secondary outcomes

  1. Post surgery risk

    Risk stratification based on the correlation of the measurements obtained from the primary objective on outcome (complication vs non complication).

    Time frame: 72 hours post LSG

07

Study locations

1 site
  • Deaprtment of Radiology, IRCCS Ospadale San Raffaele
    Milan, 20132, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03967860
Lead sponsor
Francesco De Cobelli
Responsible party
Francesco De Cobelli (Professor of Radiology, Director of Specialiaztion School in Radiology, Head of Clinical and Experimental Radiology, IRCCS San Raffaele) — Sponsor-investigator
First posted
May 30, 2019
Start date
Mar 6, 2019
Primary completion
May 6, 2019
Completion
May 6, 2019
Last update
Sep 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion